Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

MBIO

Mustang Bio (MBIO)

Mustang Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MBIO
DatumZeitQuelleÜberschriftSymbolFirma
02/01/202522h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
06/12/202423h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MBIOMustang Bio Inc
02/12/202422h45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBIOMustang Bio Inc
29/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBIOMustang Bio Inc
22/11/202422h45Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
15/11/202422h50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
12/11/202414h30GlobeNewswire Inc.Mustang Bio Receives Positive Listing Determination from NasdaqNASDAQ:MBIOMustang Bio Inc
08/11/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MBIOMustang Bio Inc
07/11/202414h30GlobeNewswire Inc.Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant GliomaNASDAQ:MBIOMustang Bio Inc
06/11/202423h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
29/10/202421h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
25/10/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
24/10/202420h10GlobeNewswire Inc.Mustang Bio Announces Exercise of Warrants for $4 Million Gross ProceedsNASDAQ:MBIOMustang Bio Inc
13/09/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
16/08/202423h08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBIOMustang Bio Inc
13/08/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MBIOMustang Bio Inc
30/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBIOMustang Bio Inc
19/07/202423h26Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
10/07/202422h41Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:MBIOMustang Bio Inc
21/06/202422h01GlobeNewswire Inc.Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:MBIOMustang Bio Inc
20/06/202414h00GlobeNewswire Inc.Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:MBIOMustang Bio Inc
20/06/202414h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBIOMustang Bio Inc
17/06/202414h30GlobeNewswire Inc.Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T TherapyNASDAQ:MBIOMustang Bio Inc
13/06/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBIOMustang Bio Inc
06/06/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
05/06/202402h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
05/06/202402h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
31/05/202423h09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
21/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
13/05/202412h01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBIOMustang Bio Inc
 Showing the most relevant articles for your search:NASDAQ:MBIO

Kürzlich von Ihnen besucht

Delayed Upgrade Clock